Key statistics
As of last trade, PureTech Health PLC (PRTC:LSE) traded at 165.60, 19.35% above the 52 week low of 138.75 set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 160.00 |
---|---|
High | 167.00 |
Low | 160.00 |
Bid | 165.40 |
Offer | 166.20 |
Previous close | 162.00 |
Average volume | 773.52k |
---|---|
Shares outstanding | 239.42m |
Free float | 201.37m |
P/E (TTM) | -- |
Market cap | 389.83m GBP |
EPS (TTM) | -0.239 GBP |
Data delayed at least 15 minutes, as of Nov 22 2024 10:53 GMT.
More ▼
- PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- PureTech to Present at Two Upcoming Investor Conferences
- PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
- PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
- PureTech to Present at CHEST 2024 Annual Meeting
- PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
- PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
- PureTech Health plc – Half-Year Report
More ▼